Clinical Trial Update: Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment [Phase 3]

View source ↗

Summary

Phase 3 double-blind, placebo-controlled study assessing whether escitalopram reduces emotional distress in head and neck cancer patients during cancer treatmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Carcinomas | Phase 3 | Status: UNKNOWN